Use of warfarin therapy at a target international normalized ratio of 3.0 for cutaneous polyarteritis nodosa

Journal of the American Academy of Dermatology

Volumn 63, Issue 4, 2010, Pages 602-606

  Kawakami, Tamihiro ^a   Soma, Yoshinao ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

anti phosphatidylserine prothrombin complex antibody; anti phospholipid antibodies; cutaneous polyarteritis nodosa; international normalized ratio; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIBODY; ANTITHROMBOCYTIC AGENT; ARGATROBAN; C REACTIVE PROTEIN; CILOSTAZOL; CLOPIDOGREL; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHATIDYLSERINE PROTHROMBIN COMPLEX ANTIBODY; PHOSPHOLIPID ANTIBODY; PREDNISONE; PROSTAGLANDIN E1; PSORALEN; UNCLASSIFIED DRUG; WARFARIN; ANTICOAGULANT AGENT; PROTHROMBIN;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL EVALUATION; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEG ULCER; MICROSCOPY; MYALGIA; NECROTIZING ARTERITIS; PARESTHESIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN BIOPSY; SKIN POLYARTERITIS NODOSA; STELLATE CELL; SUBCUTANEOUS FAT; TREATMENT FAILURE; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION; COMPLICATION; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; EPIDEMIOLOGY; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; POLYARTERITIS NODOSA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WOUND HEALING; YOUNG ADULT;

ADULT; ANTICOAGULANTS; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERNATIONAL NORMALIZED RATIO; LEG ULCER; MIDDLE AGED; POLYARTERITIS NODOSA; PROTHROMBIN; RETROSPECTIVE STUDIES; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WARFARIN; WOUND HEALING; YOUNG ADULT;

EID: 77956721748     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.10.033     Document Type: Article

References (17)

1. J.L. Díaz-Pérez, Z.M. De Lagrán, J.L. Díaz-Ramón, and R.K. Winkelmann Cutaneous polyarteritis nodosa Semin Cutan Med Surg 26 2007 77 86
2. T. Kawakami, M. Yamazaki, M. Mizoguchi, and Y. Soma High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa Arthritis Rheum 57 2007 1507 1513
3. J.S. Levine, D.W. Branch, and J. Rauch The antiphospholipid syndrome N Engl J Med 346 2002 752 763
4. J. Arnout, and J. Vermylen Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease J Thromb Haemost 1 2003 931 942
5. D. Erkan, and M.D. Lockshin How much warfarin is enough in APS related thrombosis? Thromb Res 114 2004 435 442
6. T. Kawakami, M. Yamazaki, M. Mizoguchi, and Y. Soma High titer of serum antiphospholipid antibody levels in adult Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis Arthritis Rheum 59 2008 561 567
7. T. Kawakami, S. Ooka, M. Mizoguchi, Y. Soma, and M. Yamazaki Remission of hepatitis B virus-related cryoglobulinemic vasculitis with entecavir Ann Intern Med 149 2008 911 912
8. M.A. Khamashta, M.J. Cuadrado, F. Mujic, N.A. Taub, B.J. Hunt, and G.R.V. Hughes The management of thrombosis in the antiphospholipid-antibody syndrome N Engl J Med 332 1995 993 997
9. M.H. Rosove, and P.M. Brewer Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients Ann Intern Med 117 1992 303 308
10. R.H. Derksen, P.G. de Groot, L. Kater, and H.K. Nieuwenhuis Patients with antiphospholipid antibodies and venous thrombosis should receive long-term anticoagulant treatment Ann Rheum Dis 52 1993 689 692
11. S. Schulman, E. Svenungsson, and S. Granqvist Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group Am J Med 104 1998 332 338
12. J.S. Ginsberg, P.S. Wells, P. Brill-Edwards, D. Donovan, K. Moffatt, and M. Johnston Antiphospholipid antibodies and venous thromboembolism Blood 86 1995 3685 3691
13. P. Prandoni, P. Simioni, and A. Girolami Antiphospholipid antibodies, recurrent thromboembolism, and intensity of warfarin anticoagulation Thromb Haemost 75 1996 859
14. A. Rance, J. Emmerich, and J.N. Fiessinger Anticardiolipin antibodies and recurrent thromboembolism Thromb Haemost 77 1997 221 222
15. M.A. Crowther, J.S. Ginsberg, J. Julian, J. Denburg, J. Hirsh, and J. Douketis A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome N Engl J Med 349 2003 1133 1138
16. W. Lim, M.A. Crowther, and J.W. Eikelboom Management of antiphospholipid antibody syndrome: A systematic review JAMA 295 2006 1050 1057
17. D. Erkan, and M.D. Lockshin New treatments for antiphospholipid syndrome Rheum Dis Clin North Am 32 2006 129 148